Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells
Purpose Myrrh, the oleo-gum resin of Commiphora molmol , is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, t...
Gespeichert in:
Veröffentlicht in: | International journal of colorectal disease 2017-05, Vol.32 (5), p.623-634 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 634 |
---|---|
container_issue | 5 |
container_start_page | 623 |
container_title | International journal of colorectal disease |
container_volume | 32 |
creator | Rosenthal, Rita Luettig, Julia Hering, Nina A. Krug, Susanne M. Albrecht, Uwe Fromm, Michael Schulzke, Jörg-Dieter |
description | Purpose
Myrrh, the oleo-gum resin of
Commiphora molmol
, is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, this study investigates the effect of myrrh on paracellular barrier function in the absence or presence of the pro-inflammatory cytokine TNFα.
Methods
Monolayers of human colon cell lines HT-29/B6 and Caco-2 were incubated with myrrh under control conditions or after challenge with the pro-inflammatory cytokine TNFα. Barrier function was analysed by electrophysiological and permeability measurements, Western blotting, immunostaining in combination with confocal microscopy, and freeze-fracture electron microscopy.
Results
In Caco-2 cells, myrrh induced an increase in transepithelial resistance (TER) which was associated with downregulation of the channel-forming tight junction (TJ) protein claudin-2 via inhibition of the PI3 kinase signalling pathway. In HT-29/B6 cells, myrrh had no effect on barrier properties under basic conditions, but protected against barrier damage induced by TNFα, as indicated by a decrease in TER and an increase in fluorescein permeability. The TNFα effect was associated with a redistribution of the sealing TJ protein claudin-1, an increase in the expression of claudin-2 and a change in TJ ultrastructure. Most importantly, all TNFα effects were inhibited by myrrh. The effect of myrrh on claudin-2 expression in this cell line was mediated via inhibition of the STAT6 pathway.
Conclusions
This study shows for the first time that myrrh exerts barrier-stabilising and TNFα-antagonising effects in human intestinal epithelial cell models via inhibition of PI3K and STAT6 signalling. This suggests therapeutic application of myrrh in intestinal diseases associated with barrier defects and inflammation. |
doi_str_mv | 10.1007/s00384-016-2736-x |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1897392677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714489316</galeid><sourcerecordid>A714489316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-bf3b588b13b2cf93d8c19e9a3a524b89d293595af76672c9c646a033cb1941673</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhi0EokvhB3BBkbhwceuv-ONYVtAiFfXSni3bGW9dssliZ6vtv8fptqggkCofPB4_7_gdeRB6T8kRJUQdF0K4FphQiZniEu9eoAUVnGHKJHuJFoQqg6lp9QF6U8oNqWepxGt0wJTRlCu1QD--3-V83cAO8lQa73JOkHGZnE99KmlYNW7oGrzJ4wRhSrfQQIw1Kk0amrNLzMzxZ3nPLF0YMavpCcqUBtc3sEnTNfSphgH6vrxFr6LrC7x72A_R1dcvl8szfH5x-m15co6DUGzCPnLfau0p9yxEwzsdqAHjuGuZ8Np0zPDWtC4qKRULJkghHeE8eGoElYofok_7utX1z211Y9epzA7cAOO2WKqN4oZJ9Ry0ZVLXh0xFP_6F3ozbXPucKW2EIMQ8oVauB5uGOE7ZhbmoPVFUCG04lZU6-gdVVwfrFMYBYqr5PwR0Lwh5LCVDtJuc1i7fWUrsPAt2Pwu2zoKdZ8HuqubDg-GtX0P3W_H4-RVge6DUq2EF-UlH_636Cyawu88</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1889440099</pqid></control><display><type>article</type><title>Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Rosenthal, Rita ; Luettig, Julia ; Hering, Nina A. ; Krug, Susanne M. ; Albrecht, Uwe ; Fromm, Michael ; Schulzke, Jörg-Dieter</creator><creatorcontrib>Rosenthal, Rita ; Luettig, Julia ; Hering, Nina A. ; Krug, Susanne M. ; Albrecht, Uwe ; Fromm, Michael ; Schulzke, Jörg-Dieter</creatorcontrib><description>Purpose
Myrrh, the oleo-gum resin of
Commiphora molmol
, is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, this study investigates the effect of myrrh on paracellular barrier function in the absence or presence of the pro-inflammatory cytokine TNFα.
Methods
Monolayers of human colon cell lines HT-29/B6 and Caco-2 were incubated with myrrh under control conditions or after challenge with the pro-inflammatory cytokine TNFα. Barrier function was analysed by electrophysiological and permeability measurements, Western blotting, immunostaining in combination with confocal microscopy, and freeze-fracture electron microscopy.
Results
In Caco-2 cells, myrrh induced an increase in transepithelial resistance (TER) which was associated with downregulation of the channel-forming tight junction (TJ) protein claudin-2 via inhibition of the PI3 kinase signalling pathway. In HT-29/B6 cells, myrrh had no effect on barrier properties under basic conditions, but protected against barrier damage induced by TNFα, as indicated by a decrease in TER and an increase in fluorescein permeability. The TNFα effect was associated with a redistribution of the sealing TJ protein claudin-1, an increase in the expression of claudin-2 and a change in TJ ultrastructure. Most importantly, all TNFα effects were inhibited by myrrh. The effect of myrrh on claudin-2 expression in this cell line was mediated via inhibition of the STAT6 pathway.
Conclusions
This study shows for the first time that myrrh exerts barrier-stabilising and TNFα-antagonising effects in human intestinal epithelial cell models via inhibition of PI3K and STAT6 signalling. This suggests therapeutic application of myrrh in intestinal diseases associated with barrier defects and inflammation.</description><identifier>ISSN: 0179-1958</identifier><identifier>EISSN: 1432-1262</identifier><identifier>DOI: 10.1007/s00384-016-2736-x</identifier><identifier>PMID: 27981377</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Analysis ; Caco-2 Cells ; Chamomile - chemistry ; Charcoal - pharmacology ; Coffee - chemistry ; Colitis ; Enterocytes - cytology ; Enterocytes - drug effects ; Enterocytes - metabolism ; Gastroenterology ; Gastrointestinal diseases ; Hepatology ; HT29 Cells ; Humans ; Internal Medicine ; Medicine ; Medicine & Public Health ; Models, Biological ; Original Article ; Permeability ; Proctology ; Protective Agents - pharmacology ; Protein Transport - drug effects ; Resins, Plant - pharmacology ; Signal Transduction - drug effects ; Surgery ; Tight Junction Proteins - metabolism ; Tight Junctions - drug effects ; Tight Junctions - metabolism ; Tight Junctions - ultrastructure ; Tumor necrosis factor ; Tumor Necrosis Factor-alpha - pharmacology ; Wildlife conservation</subject><ispartof>International journal of colorectal disease, 2017-05, Vol.32 (5), p.623-634</ispartof><rights>Springer-Verlag Berlin Heidelberg 2017</rights><rights>COPYRIGHT 2017 Springer</rights><rights>International Journal of Colorectal Disease is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-bf3b588b13b2cf93d8c19e9a3a524b89d293595af76672c9c646a033cb1941673</citedby><cites>FETCH-LOGICAL-c472t-bf3b588b13b2cf93d8c19e9a3a524b89d293595af76672c9c646a033cb1941673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00384-016-2736-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00384-016-2736-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27981377$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosenthal, Rita</creatorcontrib><creatorcontrib>Luettig, Julia</creatorcontrib><creatorcontrib>Hering, Nina A.</creatorcontrib><creatorcontrib>Krug, Susanne M.</creatorcontrib><creatorcontrib>Albrecht, Uwe</creatorcontrib><creatorcontrib>Fromm, Michael</creatorcontrib><creatorcontrib>Schulzke, Jörg-Dieter</creatorcontrib><title>Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells</title><title>International journal of colorectal disease</title><addtitle>Int J Colorectal Dis</addtitle><addtitle>Int J Colorectal Dis</addtitle><description>Purpose
Myrrh, the oleo-gum resin of
Commiphora molmol
, is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, this study investigates the effect of myrrh on paracellular barrier function in the absence or presence of the pro-inflammatory cytokine TNFα.
Methods
Monolayers of human colon cell lines HT-29/B6 and Caco-2 were incubated with myrrh under control conditions or after challenge with the pro-inflammatory cytokine TNFα. Barrier function was analysed by electrophysiological and permeability measurements, Western blotting, immunostaining in combination with confocal microscopy, and freeze-fracture electron microscopy.
Results
In Caco-2 cells, myrrh induced an increase in transepithelial resistance (TER) which was associated with downregulation of the channel-forming tight junction (TJ) protein claudin-2 via inhibition of the PI3 kinase signalling pathway. In HT-29/B6 cells, myrrh had no effect on barrier properties under basic conditions, but protected against barrier damage induced by TNFα, as indicated by a decrease in TER and an increase in fluorescein permeability. The TNFα effect was associated with a redistribution of the sealing TJ protein claudin-1, an increase in the expression of claudin-2 and a change in TJ ultrastructure. Most importantly, all TNFα effects were inhibited by myrrh. The effect of myrrh on claudin-2 expression in this cell line was mediated via inhibition of the STAT6 pathway.
Conclusions
This study shows for the first time that myrrh exerts barrier-stabilising and TNFα-antagonising effects in human intestinal epithelial cell models via inhibition of PI3K and STAT6 signalling. This suggests therapeutic application of myrrh in intestinal diseases associated with barrier defects and inflammation.</description><subject>Analysis</subject><subject>Caco-2 Cells</subject><subject>Chamomile - chemistry</subject><subject>Charcoal - pharmacology</subject><subject>Coffee - chemistry</subject><subject>Colitis</subject><subject>Enterocytes - cytology</subject><subject>Enterocytes - drug effects</subject><subject>Enterocytes - metabolism</subject><subject>Gastroenterology</subject><subject>Gastrointestinal diseases</subject><subject>Hepatology</subject><subject>HT29 Cells</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Models, Biological</subject><subject>Original Article</subject><subject>Permeability</subject><subject>Proctology</subject><subject>Protective Agents - pharmacology</subject><subject>Protein Transport - drug effects</subject><subject>Resins, Plant - pharmacology</subject><subject>Signal Transduction - drug effects</subject><subject>Surgery</subject><subject>Tight Junction Proteins - metabolism</subject><subject>Tight Junctions - drug effects</subject><subject>Tight Junctions - metabolism</subject><subject>Tight Junctions - ultrastructure</subject><subject>Tumor necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Wildlife conservation</subject><issn>0179-1958</issn><issn>1432-1262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkk1v1DAQhi0EokvhB3BBkbhwceuv-ONYVtAiFfXSni3bGW9dssliZ6vtv8fptqggkCofPB4_7_gdeRB6T8kRJUQdF0K4FphQiZniEu9eoAUVnGHKJHuJFoQqg6lp9QF6U8oNqWepxGt0wJTRlCu1QD--3-V83cAO8lQa73JOkHGZnE99KmlYNW7oGrzJ4wRhSrfQQIw1Kk0amrNLzMzxZ3nPLF0YMavpCcqUBtc3sEnTNfSphgH6vrxFr6LrC7x72A_R1dcvl8szfH5x-m15co6DUGzCPnLfau0p9yxEwzsdqAHjuGuZ8Np0zPDWtC4qKRULJkghHeE8eGoElYofok_7utX1z211Y9epzA7cAOO2WKqN4oZJ9Ry0ZVLXh0xFP_6F3ozbXPucKW2EIMQ8oVauB5uGOE7ZhbmoPVFUCG04lZU6-gdVVwfrFMYBYqr5PwR0Lwh5LCVDtJuc1i7fWUrsPAt2Pwu2zoKdZ8HuqubDg-GtX0P3W_H4-RVge6DUq2EF-UlH_636Cyawu88</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Rosenthal, Rita</creator><creator>Luettig, Julia</creator><creator>Hering, Nina A.</creator><creator>Krug, Susanne M.</creator><creator>Albrecht, Uwe</creator><creator>Fromm, Michael</creator><creator>Schulzke, Jörg-Dieter</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells</title><author>Rosenthal, Rita ; Luettig, Julia ; Hering, Nina A. ; Krug, Susanne M. ; Albrecht, Uwe ; Fromm, Michael ; Schulzke, Jörg-Dieter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-bf3b588b13b2cf93d8c19e9a3a524b89d293595af76672c9c646a033cb1941673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Analysis</topic><topic>Caco-2 Cells</topic><topic>Chamomile - chemistry</topic><topic>Charcoal - pharmacology</topic><topic>Coffee - chemistry</topic><topic>Colitis</topic><topic>Enterocytes - cytology</topic><topic>Enterocytes - drug effects</topic><topic>Enterocytes - metabolism</topic><topic>Gastroenterology</topic><topic>Gastrointestinal diseases</topic><topic>Hepatology</topic><topic>HT29 Cells</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Models, Biological</topic><topic>Original Article</topic><topic>Permeability</topic><topic>Proctology</topic><topic>Protective Agents - pharmacology</topic><topic>Protein Transport - drug effects</topic><topic>Resins, Plant - pharmacology</topic><topic>Signal Transduction - drug effects</topic><topic>Surgery</topic><topic>Tight Junction Proteins - metabolism</topic><topic>Tight Junctions - drug effects</topic><topic>Tight Junctions - metabolism</topic><topic>Tight Junctions - ultrastructure</topic><topic>Tumor necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Wildlife conservation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosenthal, Rita</creatorcontrib><creatorcontrib>Luettig, Julia</creatorcontrib><creatorcontrib>Hering, Nina A.</creatorcontrib><creatorcontrib>Krug, Susanne M.</creatorcontrib><creatorcontrib>Albrecht, Uwe</creatorcontrib><creatorcontrib>Fromm, Michael</creatorcontrib><creatorcontrib>Schulzke, Jörg-Dieter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of colorectal disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosenthal, Rita</au><au>Luettig, Julia</au><au>Hering, Nina A.</au><au>Krug, Susanne M.</au><au>Albrecht, Uwe</au><au>Fromm, Michael</au><au>Schulzke, Jörg-Dieter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells</atitle><jtitle>International journal of colorectal disease</jtitle><stitle>Int J Colorectal Dis</stitle><addtitle>Int J Colorectal Dis</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>32</volume><issue>5</issue><spage>623</spage><epage>634</epage><pages>623-634</pages><issn>0179-1958</issn><eissn>1432-1262</eissn><abstract>Purpose
Myrrh, the oleo-gum resin of
Commiphora molmol
, is well known for its anti-inflammatory properties. In different animal models, it protected against DSS-, TNBS- and oxazolone-induced colitis. To date, no information concerning the effect of myrrh on barrier properties are available. Thus, this study investigates the effect of myrrh on paracellular barrier function in the absence or presence of the pro-inflammatory cytokine TNFα.
Methods
Monolayers of human colon cell lines HT-29/B6 and Caco-2 were incubated with myrrh under control conditions or after challenge with the pro-inflammatory cytokine TNFα. Barrier function was analysed by electrophysiological and permeability measurements, Western blotting, immunostaining in combination with confocal microscopy, and freeze-fracture electron microscopy.
Results
In Caco-2 cells, myrrh induced an increase in transepithelial resistance (TER) which was associated with downregulation of the channel-forming tight junction (TJ) protein claudin-2 via inhibition of the PI3 kinase signalling pathway. In HT-29/B6 cells, myrrh had no effect on barrier properties under basic conditions, but protected against barrier damage induced by TNFα, as indicated by a decrease in TER and an increase in fluorescein permeability. The TNFα effect was associated with a redistribution of the sealing TJ protein claudin-1, an increase in the expression of claudin-2 and a change in TJ ultrastructure. Most importantly, all TNFα effects were inhibited by myrrh. The effect of myrrh on claudin-2 expression in this cell line was mediated via inhibition of the STAT6 pathway.
Conclusions
This study shows for the first time that myrrh exerts barrier-stabilising and TNFα-antagonising effects in human intestinal epithelial cell models via inhibition of PI3K and STAT6 signalling. This suggests therapeutic application of myrrh in intestinal diseases associated with barrier defects and inflammation.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27981377</pmid><doi>10.1007/s00384-016-2736-x</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0179-1958 |
ispartof | International journal of colorectal disease, 2017-05, Vol.32 (5), p.623-634 |
issn | 0179-1958 1432-1262 |
language | eng |
recordid | cdi_proquest_miscellaneous_1897392677 |
source | MEDLINE; SpringerLink Journals |
subjects | Analysis Caco-2 Cells Chamomile - chemistry Charcoal - pharmacology Coffee - chemistry Colitis Enterocytes - cytology Enterocytes - drug effects Enterocytes - metabolism Gastroenterology Gastrointestinal diseases Hepatology HT29 Cells Humans Internal Medicine Medicine Medicine & Public Health Models, Biological Original Article Permeability Proctology Protective Agents - pharmacology Protein Transport - drug effects Resins, Plant - pharmacology Signal Transduction - drug effects Surgery Tight Junction Proteins - metabolism Tight Junctions - drug effects Tight Junctions - metabolism Tight Junctions - ultrastructure Tumor necrosis factor Tumor Necrosis Factor-alpha - pharmacology Wildlife conservation |
title | Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T08%3A35%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myrrh%20exerts%20barrier-stabilising%20and%20-protective%20effects%20in%20HT-29/B6%20and%20Caco-2%20intestinal%20epithelial%20cells&rft.jtitle=International%20journal%20of%20colorectal%20disease&rft.au=Rosenthal,%20Rita&rft.date=2017-05-01&rft.volume=32&rft.issue=5&rft.spage=623&rft.epage=634&rft.pages=623-634&rft.issn=0179-1958&rft.eissn=1432-1262&rft_id=info:doi/10.1007/s00384-016-2736-x&rft_dat=%3Cgale_proqu%3EA714489316%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1889440099&rft_id=info:pmid/27981377&rft_galeid=A714489316&rfr_iscdi=true |